Stem cells reside in a specialized regulatory microenvironment or niche 1, 2 , where they receive appropriate support for maintaining selfrenewal and multi-lineage differentiation capacity [1] [2] [3] . The niche may also protect stem cells from environmental insults 3 including cytotoxic chemotherapy and perhaps pathogenic immunity 4 . The testis, hair follicle and placenta are all sites of residence for stem cells and are immune-suppressive environments, called immune-privileged sites, where multiple mechanisms cooperate to prevent immune attack, even enabling prolonged survival of foreign allografts without immunosuppression 4 . We sought to determine if somatic stem-cell niches more broadly are immune-privileged sites by examining the haematopoietic stem/progenitor cell (HSPC) niche 1, 2, [5] [6] [7] in the bone marrow, a site where immune reactivity exists 8, 9 . We observed persistence of HSPCs from allogeneic donor mice (allo-HSPCs) in nonirradiated recipient mice for 30 days without immunosuppression with the same survival frequency compared to syngeneic HSPCs. These HSPCs were lost after the depletion of FoxP3 regulatory T (T reg ) cells. High-resolution in vivo imaging over time demonstrated marked co-localization of HSPCs with T reg cells that accumulated on the endosteal surface in the calvarial and trabecular bone marrow. T reg cells seem to participate in creating a localized zone where HSPCs reside and where T reg cells are necessary for allo-HSPC persistence. In addition to processes supporting stem-cell function, the niche will provide a relative sanctuary from immune attack.
Despite rapid advances in our understanding of adult stem-cell biology, the immunological attributes of somatic stem-cell niches have remained largely unexplored. We hypothesized that the HSPC niche within the bone marrow 6, 7 is an immune-privileged site based on the observation that human bone marrow contains a higher frequency of CD4
FoxP3
1 regulatory T (T reg ) cells than other secondary lymphoid organs 10 . We used intravital microscopy (IVM) [11] [12] [13] to visualize the localization of T reg cells and transplanted HSPCs within the bone marrow of live animals.
Prolonged survival of allografts or xenografts without immunosuppression was a criterion used previously to demonstrate immune privilege in sites such as the testis, the eye and the brain 4 . To test if the HSPC niche is an immune-privileged site that meets the above criterion, we first examined if allo-HSPCs transplanted into nonirradiated recipients would survive without any immunosuppression. C57BL/6 (hereafter called B6) C-kit Fig. 1) . Surprisingly, the numbers of surviving KSL cells in the skull bone marrow were comparable in the syngeneic and allogeneic recipients (Fig. 1a, b and Supplementary Fig. 1 ). Approximately 90% of the donor cells in both recipients were found near the endosteal surface, a location that has been identified as an HSPC niche 6, 7 (Fig. 1c) . Most KSL cells in both syngeneic and allogeneic groups retained high levels of DiD, indicating that HSPCs did not undergo extensive proliferation. B6-derived cells were not detected in the blood by flow cytometry (data not shown).
Phenotypic analysis showed that surviving donor cells contained a significant fraction of B6 KSL HSPCs and CD150
1

CD48
2 KSL haematopoietic stem cells (HSCs) (Supplementary Fig. 2 ). To determine if they contain functional HSCs, we performed secondary transplant of BALB/c recipient bone marrow into sub-lethally irradiated B6 mice and confirmed long-term multi-lineage reconstitution derived from first donor cells ( Supplementary Fig. 3 and Supplementary Table) . These results indicate that HSCs with long-term repopulating potential persisted in non-irradiated allogeneic recipients without immunosuppression.
Reciprocal transplant of BALB/c CD150
1
CD48
2
Lin
2 HSPCs into B6 mice shows that allo-HSPCs can survive in non-irradiated mice regardless of the combination of strains used as donors and recipients ( Supplementary Fig. 4) .
To explore the possibility that immune ignorance may be the cause of the prolonged survival of allo-HSPCs in non-irradiated recipients, we first examined major histocompatibility complex class I antigen expression and found higher levels of H2-Kb on B6 KSL cells than on spleen CD19
1 B cells (data not shown) 14 . To address the possibility that transplantation of KSL cells alone without differentiated cells may fail to evoke a potent allogeneic immune response, we transplanted DiD-labelled KSL cells (5 3 10 4 per mouse) alone or with non-labelled B6 whole bone marrow cells (5 3 10 7 per mouse) into non-irradiated BALB/c recipients and detected comparable numbers of surviving DiD-positive B6 cells with or without co-transplantation of whole bone marrow cells (Fig. 1b) . The inability of the host to reject these cells is therefore probably not due to immune ignorance, but may reflect active immune regulation.
We next tested if prolonged survival of allogeneic cells in nonirradiated recipients is unique to HSPCs. We simultaneously injected B6 KSL HSPCs and B6 Lin 1 differentiated cells labelled with two different dyes, DiD and DiI (1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate), into non-irradiated BALB/c or B6 mice. In vivo imaging of the skull bone marrows of the allogeneic BALB/c recipients 2 days later showed the presence of both DiI-labelled B6 Lin 1 cells and DiD-labelled B6 KSL cells (Fig. 1d ), but in contrast to the KSL cells, the Lin 1 cells were distributed farther away from the endosteal surface ( Supplementary Fig. 5 ). Notably, on day 7, Lin 1 cells were virtually undetectable, whereas the HSPCs persisted (Fig. 1d) . In the syngeneic B6 recipients, both populations survived for 7 days (Fig. 1d) .
Prolonged survival of allo-HSPCs in non-irradiated recipients is consistent with earlier observations of prolonged survival of transplanted allogeneic/xenogeneic grafts in other immune-privileged sites 4 , supporting our hypothesis that the HSPC niche also has immune-privileged mechanisms that shield the transplanted alloHSPCs, but not their differentiated counterpart, from allogeneic immune response.
Next, we examined the relevance of T reg cells to immune privilege in the HSPC niche. We confirmed that the frequency of FoxP3 T reg cells in CD4 T cells is higher in the bone marrow (23%) than in the spleen (13%) and lymph nodes (13%) (data not shown). As the trafficking of T reg cells to the bone marrow critically depends on the stem-cell chemo-attractant SDF-1 (ref. 10) , which is expressed at high levels by cellular components of the HSPC niche 13, [15] [16] [17] , we proposed that T reg cells will accumulate in the HSPC niche and render it immune suppressive. In vivo three-dimensional imaging of the intact skull and mechanically thinned proximal tibia of FoxP3-GFP mice, whose FoxP3 1 cells specifically express the green fluorescent protein (GFP), showed that 58% (203 of 350) and 72% (137 of 191), respectively, of T reg cells were within 15 mm of the endosteal surface (Fig. 2a, b) . Preferential localization of T reg cells on the endosteal surface was also confirmed by analysis of two-dimensional histological sections ( Fig. 2b and Supplementary Fig. 6 ).
Next, we examined the relative spatial distribution of T reg cells and transplanted HSPCs by in vivo three-dimensional imaging. Notably, .80% of the DiD-labelled B6 KSL cells homed within 20 mm of T reg cells on the endosteal surface 24 h after intravenous injection into FoxP3-GFP B6 mice (Fig. 2a, c) . In contrast, Lin 1 differentiated cells were much less likely to home close to T reg cells (Fig. 2c) . Close proximity of transplanted KSL cells and T reg cells on the endosteal surface was confirmed by histological analysis of the tibia and femur trabecular bone marrow ( Supplementary Fig. 6 ). We also visualized the quiescent HSCs after administering the chemotherapy drug 5-fluorouracil (5-FU), which selectively killed dividing cells. In vivo imaging of the skull bone marrow 48 h after 5-FU treatment showed that 82% (36 of 44) of the 5-FU-resistant DiD-labelled KSL cells were within 20 mm of 
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the FoxP3-GFP T reg cells (Fig. 2d ), forming clusters with T reg cells on the endosteal surface. Similarly, T reg cells accumulated around alloHSPCs that survived on the endosteal surface of the skull bone marrow and trabecular bone marrow of long bones in non-irradiated mice for 30 days without immunosuppression ( Fig. 2e and Supplementary Fig.  7 ). In cortical bone marrow of long bones, only 32% (38 of 120) of alloHSPCs and 11% (15 of 137) of T reg cells were within 15 mm of the endosteal surface, but proximity of T reg cells to allo-HSPCs was still noted irrespective of their distance to the endosteal surface ( Fig. 2b and Supplementary Fig. 7 ).
To examine whether T reg cells have a critical role in providing immune privilege to the HSPC niche, we examined if depletion of T reg cells resulted in the rejection of allo-HSPCs without immunosuppression. Using FoxP3-GFP diphtheria toxin receptor (DTR) mice, the T reg cells of which express DTR and can be specifically depleted by diphtheria toxin treatment (data not shown), we observed a 70% reduction in the number of surviving donor cells in diphtheria-toxin-treated versus control-vehicle-treated recipients (Fig. 3a) . Depletion of T reg cells by anti-CD25 antibody also led to a 90% reduction in the number of surviving donor cells compared with control-antibody-treated ≤20  ≤25  ≤30  ≤35  ≤40  ≤45  ≤50  ≤55  ≤60  ≤65  ≤70  ≤75  ≤80  ≤85  ≤90  ≤95  ≤100 Fig. 8 ). Quantitative PCR with reverse transcription (qRT-PCR) analysis of CD4 1
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2 T cells and CD8
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T cells isolated from the bone marrow showed increased levels of TNF-a and IL-4 expression in diphtheria-toxin-treated versus control B6N9 FoxP3-GFP DTR mice transplanted with BALB/c HSPCs ( Supplementary Fig. 9 ). Together these results indicate that T reg cells critically provide the HSPC niche with immune privilege and that T reg -cell-mediated suppression of bone marrow CD4 and CD8 T-cell activation is at least in part responsible for the survival of allo-HSPCs in non-irradiated hosts without immunosuppression. We also performed qRT-PCR analysis of T reg cells from B6 FoxP3-GFP recipients 6 days after transplantation of BALB/c CD150
Lin
2 HSPCs without immunosuppression. Tgfb mRNA level in bone marrow FoxP3 T reg cells was fourfold higher than in spleen T reg cells of transplanted recipients, but this level was comparable to that in bone marrow T reg cells of non-transplanted recipients (Fig. 3b) . In contrast, IL10 mRNA level in bone marrow T reg cells of transplanted recipients was significantly higher compared with control bone marrow T reg cells without transplant, and was also significantly higher compared with spleen T reg cells of transplanted mice (Fig. 3b) . Increased expression of IL-10 at the protein level in bone marrow FoxP3 T reg cells was also confirmed using fluorescenceactivated cell sorting (FACS) analysis after intracellular staining (Fig. 3c) . Consistent with these findings, anti-IL-10R antibody treatment led to ,90% reduction of the number of surviving allo-HSPCs compared with control IgG antibody treatment, whereas anti-TGF-b antibody treatment did not have a significant effect on the number of donor cells (Fig. 3d) .
To test the specific role of IL-10 in T reg cells, we used as transplant recipients non-irradiated B6 RAG2 knockout mice reconstituted 1 day earlier with B6 IL-10 knockout CD4 T cells (Fig. 3e) . Together, the data indicate that IL-10 from T reg cells is critical for T reg -mediated immune protection of allo-HSPCs in nonirradiated recipients. We show here that in anatomical locations where immune activity is otherwise known to occur 8, 9 , discrete sites of immune privilege may exist and contribute to a somatic stem-cell niche. Prolonged survival of allo-HSPCs without immunosuppression is surprising and seems contrary to the clinical experience that indicates strong immunosuppression is required to prevent rejection in allogeneic bone marrow transplantation 18 . We propose that our data may not be in conflict with that well-defined experience because we are observing events at the level of the HSPC in non-irradiated hosts, whereas the clinical transplant measure of engraftment is mature cell chimaerism. In transplantation without immunosuppression, mature cells are susceptible to immune attack and low levels of HSPC chimaerism in the relative absence of proliferation may go undetected by conventional methods.
T reg cells accumulate in the HSPC niche and may provide the HSPC niche with immune privilege mechanisms, enabling transplanted allo-HSPCs to escape from allogeneic rejection. Immune privilege mechanisms of the HSPC niche will shield endogenous HSPCs from autoimmunity or excessive inflammation, and will even help malignant cells to evade host immunity. This work raises the possibility of niches in other tissues serving as immune-privileged sites.
METHODS SUMMARY
All mice were housed according to IACUC guidelines and used for experiments when 8-14-weeks old. Mice were anaesthetized and prepared for in vivo imaging as described previously 12, 13 . The mouse was held in a heated tube mounted on a precision 3-axis motorized stage (Sutter MP385). All mice were imaged with a custom-built confocal two-photon hybrid microscope specifically designed for live-animal imaging (see Methods). Using the crossing of the central vein and coronal sutures as landmarks, we imaged identical areas of the skull (,1,650 mm 3 2,310 mm) encompassing most of the parasagittal bone marrow cavities 12, 13 . We acquired three-dimensional stacks consisting of 31 optical sections with 5 mm z spacing, which provide image volumes 150 mm in depth, reaching approximately 40-60% into the bone marrow cavity 12 .
Image processing and HSPC-microenvironment distance measurements were obtained using ImageJ 12 . A two-tailed t-test was applied in the two-group analysis. P values # 0.05 were considered to be statistically significant. In the three and four group comparisons, we performed one-way analysis of variance followed by an analysis of the three pairwise differences of interest using Bonferroni correction so that P values # 0.05/3 were considered statistically significant.
METHODS
Mouse. FoxP3-GFP knock-in mice (C57BL/6 or BALB/c background) were provided by T. Strom's laboratory. FoxP3-GFP diphtheria toxin receptor (DTR) mice were provided by Rudensky's laboratory. C57BL/6 mice, BALB/c mice and IL-10 knockout mice were purchased from Jackson laboratory. RAG2 knockout mice were purchased from Taconic. All animal experiments were performed in compliance with institutional guidelines and approved by the Subcommittee on Research Animal Care (SRAC) at Massachusetts General Hospital. Haematopoietic stem-cell isolation. Whole bone marrow was obtained from C57BL/6 mice or BALB/c mice by crushing the femur, tibia, iliac, humerus and vertebral bones. Cells were pooled and washed with PBS, then incubated in a lineage cocktail consisting of biotinylated B220, Mac1, GR-1, CD3a, CD8a, CD4 and Ter119 antibodies. After washing, cells were incubated with MACS-SA beads (Miltenyi) following the manufacturer's protocol, washed again, then separated on an LD depletion column in a MidiMACS separation unit to remove lineagespecific cell populations. Lineage-negative cells from B6 mice were then stained with C-kit and Sca1 antibodies conjugated with allophycocyanin (APC) and phycoerythrin (PE), respectively. Lineage-negative cells from BALB/c mice were stained with CD48-APC and CD150-PE antibodies. Subsequently, C-kit 
CD48
2 Lin 2 cells were fluorescently labelled by incubation with the dialkylcarbocyanine membrane dyes, 'DiD' or 'DiI'. Cells in culture media were incubated with 10 mM dye for 30 min at 37 uC. Cells were then centrifuged and the pellet washed in PBS three times before injection in animals. In vivo imaging. In vivo imaging of the bone marrow through the intact skull bone of live mice was first demonstrated elsewhere 11 . Here we used a video-rate laser scanning hybrid confocal/two-photon microscope that is specifically designed and optimized for live animal imaging 12, 13 . A polygon-based scanning engine allows simultaneous multi-channel image acquisition at video rate (30 frames per second), a feature that is particularly useful for imaging moving objects. Fast scanning speed, together with a precision computer-controlled xyz stage, also facilitate surveying large tissue volumes in three dimensions and searching for rare cells in the bone marrow.
The mice were anaesthetized with intraperitoneal injection of ketamine/xylazine, and a small incision was made in the scalp to expose the underlying skull. The skull bone was kept intact. Second harmonic microscopy was used to visualize the bone and to identify the major anatomical landmarks such as the central vein and the coronal suture. Bone is rich in type-1 collagen, which was imaged by second harmonic generation using 840 nm excitation and 420 nm detection. Using the crossing of the central vein and coronal sutures as landmarks, we imaged identical areas of the skull (,1,650 mm 3 2,310 mm) encompassing most of the parasagittal bone marrow cavities 12, 13 . The maximum imaging depth was approximately 150 mm below the outer bone surface, allowing us to penetrate between 40% and 60% of bone marrow cavity space in over 75% of our measurements 12 . DiD signal was excited with a 638-nm helium-neon laser (Radius, Coherent Inc.) and detected with a photomultiplier tube through a 695 6 27.5-nm band-pass filter (Omega Optical). GFP signal was excited with a 491-nm solid state laser (Dual Calypso, Cobolt AB) and detected with a photomultiplier tube through a 528 6 19-nm band-pass filter (Semrock). Second harmonic generation signals from the bone were excited with an 840-nm titanium-sapphire laser (Spectra Physics) and detected with a photomultiplier tube through a 435 6 20-nm bandpass filter (Semrock). Each image consisted of 30 frames averaged together. Imaging duration per mouse was approximately 2 h.
For imaging the tibia bone marrow, the outer skin was removed from the leg and tendons around the joints severed to detach adjoining muscles. The saphenous and medial marginal vessels were kept intact. Upon exposure of the tibia, the medial bone surface was then gently polished with 400 grit silicon carbide wet grinding paper (Struers) while being irrigated with PBS and viewed with a surgical microscope until the fine structures of the trabecular bone became visible under the thinned cortical bone. The area was cleaned with a PBS flush and imaged using the same set-up as described above for imaging the skull bone marrow. Maximal imaging depth is approximately 150 mm below the bone surface. Histological analysis. Femurs and tibias were fixed in 4% paraformaldehyde for 4 h at room temperature, cryoprotected in 30% sucrose for 2-3 h, immersed in OCT compound (Sakura) and frozen in liquid nitrogen in the horizontal orientation. Thick frozen sections of undecalcified bone were obtained, whereby a layer of compact bone was removed from the top and the bottom of the specimen, leaving both sides of the bone marrow cavity accessible for imaging. The specimens were subsequently thawed, washed in PBS, embedded in agarose and imaged using the same set-up as described above. Image processing and analysis. Image processing and HSPC-microenvironment distance measurements were obtained using ImageJ as described previously 12 . A two-tailed t-test was applied in the two-group analysis. P values # 0.05 were considered statistically significant. In the three and four group comparison, we performed one-way analysis of variance followed by an analysis of the three pairwise differences of interest using Bonferroni correction so that P values # 0.05/3 were considered statistically significant. In vivo antibody treatment. Non-irradiated BALB/c mice were transplanted with DiD-labelled B6 KSL HSPCs. On day 0 and day 2, rat anti-CD25 antibody (1 mg per mouse, PC-61, Bio X Cell) or control rat IgG antibody (1 mg per mouse, Bio X Cell) was given intravenously. Mouse anti-IL-10R antibody, anti-TGF-b antibody or control IgG antibody treatment (200 mg per mouse, Bio X Cell) was given intraperitoneally every other day from day 21 until day 7. RNA extraction and cDNA synthesis. Isolated cells were homogenized using a 25-gauge syringe needle. Total RNA was extracted using Invitrogen's Purelink micro to midi kit and the RNA concentration was measured on a NanoDrop ND 1000 spectrophotometer (Nanodrop). Total RNA (100 ng) was converted into cDNA using a TaqMan Reverse Transcription kit (Applied Biosystems)
19
. Quantitative TaqMan PCR with reverse transcription. The ABI PRISM 7900HT Sequence Detection System was used for qRT-PCR analysis. All primer-probe sets were custom designed. Custom-designed primer-probe sets were validated by serially diluting cDNA isolated from cells expressing the target and verifying the slope, and by sequencing the amplicon. Taqman Fast PCR Master Mix was purchased from Qiagen. Amplification was carried out in a total volume of 25 ml for 40 cycles of 3 s at 95 uC, 30 s at 60 uC. Initial denaturation was performed for 3 min at 95 uC. Target gene expression was normalized by total RNA quantity used for cDNA synthesis. Immune reconstitution in RAG2 knockout mice. CD4
1
CD25
2 cells and CD4
1
CD25
1 cells were isolated from B6 mice and B6 IL-10 knockout mice. B6 RAG2 knockout mice were adoptively transferred with B6 wild-type CD4 
